Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Ned Tijdschr Geneeskd ; 1622018 10 15.
Article in Dutch | MEDLINE | ID: mdl-30379501

ABSTRACT

Self-harm among children and adolescents is a prevalent health issue. Definitions of self-harm differ, and the distinction between attempted suicide or self-harm is often unclear. A recent large population-based cohort study on self-harm among children and adolescents aged 10-29 years showed a sharp increase in the incidence of self-harm, especially in girls aged 13-16 years. It also showed an inequality in treatment offered, depending upon the socio-economic profile of the region in which the patient presented.We illustrate the problem of self-harm by presenting a clinical case, and provide advice on when to suspect self-harm and how to proceed when self-harm is suspected. Furthermore, we show that a similar increase in incidence of self-harm to that which has taken place in the UK has also been signaled in the Netherlands. Self-harm is associated with an increased risk of death by suicide and other causes of unnatural death. Evidence for therapeutic options for self-harm is limited.


Subject(s)
Self-Injurious Behavior , Suicide, Attempted , Adolescent , Child , Cohort Studies , Female , Healthcare Disparities , Humans , Incidence , Male , Netherlands/epidemiology , Prevalence , Risk Factors , Self-Injurious Behavior/epidemiology , Self-Injurious Behavior/therapy , Social Class , Socioeconomic Factors , Uncertainty
2.
Pediatr Neurol ; 42(4): 301-3, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20304339

ABSTRACT

A case of acute predominantly axonal motor and sensory neuropathy (AMSAN) is reported in a 16-year-old boy with LEOPARD syndrome (the acronym represents lentigines, ECG conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormal genitalia, retardation of growth, and sensorineural deafness). The presentation was atypical for acute motor and sensory axonal neuropathy, in that this patient had progression of symptoms of more than 4 weeks and there were signs of reinnervation in the acute phase. Treatment response to intravenous immunoglobulins was excellent. In patients with LEOPARD syndrome and acute neuropathies, treatment with intravenous immunoglobulins should be considered.


Subject(s)
Immunoglobulins, Intravenous/therapeutic use , Immunologic Factors/therapeutic use , LEOPARD Syndrome/complications , Peripheral Nervous System Diseases/complications , Peripheral Nervous System Diseases/drug therapy , Action Potentials , Acute Disease , Adolescent , Axons/physiology , Disease Progression , Humans , LEOPARD Syndrome/physiopathology , Male , Motor Neurons/physiology , Muscle, Skeletal/physiopathology , Peripheral Nervous System Diseases/physiopathology , Sensory Receptor Cells/physiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...